v3.26.1
Other Operating Income and Expenses - Narrative (Details) - JPY (¥)
¥ in Millions
12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Disclosure of other provisions [line items]      
Other ¥ 24,466 ¥ 69,650 ¥ 84,666
Post trial access cost   ¥ 27,004  
Legal proceedings provision      
Disclosure of other provisions [line items]      
Other     45,212
Legal proceedings provision | AbbVie Supply Agreement Litigation      
Disclosure of other provisions [line items]      
Other     ¥ 26,405